Quality of Life
The measurement and valuation of health and quality of life
CHERE’s quality of life research focuses on both the measurement and valuation of health and quality of life for use in the economic evaluation of health technologies. Our measurement focused research uses psychometric methods to develop new measures of quality of life and to examine existing instruments. Our valuation focused research includes the methodological development and application of preference elicitation methods such as discrete choice experiments (DCE) and time trade off to develop value sets for use in economic evaluation. Recent projects include the development of an EQ-5D-5L value set for Australia, a comparison of DCE and time trade off methods for eliciting values, the development of a new version of the SF-6D, and a large scale comparison of DCE design approaches.
Consumer and Provider Preferences
Analysis and prediction of behaviour in the health care system
Our research in this area is focused on eliciting consumer and provider preferences and identifying their impacts on the behaviour of various actors in the healthcare system. The aim is to inform the design of a consumer-friendly health system that offers relevant information and services and facilitates improved choice. We utilise several survey methods to measure preferences, including direct ratings of characteristics of care and stated preference elicitation using discrete choice experiments (DCE). By identifying important factors that contribute to the design of better health care services, the results of this research can be used to inform current policy or to investigate the consequences of hypothetical changes to policy or practice. Recent projects include investigating consumer preferences for health care performance information and identifying factors affecting GP charges and Medicare bulk-billing.
Health System Performance
Analysis of health system efficiency and equity
The evaluation of the performance of the health system involves examining the efficiency, equity, quality and sustainability of healthcare delivery, as well as the funding and financing arrangements underpinning the health system. Using national and international datasets to advance the measurement and benchmarking of these outcomes, the CHERE team works with organisations including national and state-based agencies, the OECD, WHO and the Commonwealth Fund to produce comparable health system performance research.
Health Technology Assessment
The systematic evaluation of the consequences of using health technologies
The health technology team at CHERE undertakes economic evaluations of health interventions and technologies, including safety, effectiveness, economic impacts and ethical issues associated with the introduction of health technologies. We have considerable experience in advanced economic evaluation methods and applying these to evaluate medical services, pharmaceutical products and public health interventions. Our work includes the development of economic models and evaluation of new technologies for the Medical Services Advisory Committee and the Pharmaceutical Benefits Advisory Committee. The results play a significant role in informing decision-making in the healthcare sector by ensuring that policy-makers have the necessary information to understand the comparative harms, benefits and costs of new technologies.
Policy and Program Evaluation
Evaluation of the outcomes of policy and program interventions
CHERE’s research in this area focuses on the robust evaluation of public policy interventions. Using applied econometric and quasi-experimental methods, the research uses a range of data sources including administrative survey data and data linkage methods to estimate the impacts of policy interventions on a range of economic, social and health outcomes. Recent projects have included evaluations of Medicare reforms, Healthy Homes, models of maternity care, and delivery of integrated care in rural settings.
Using health economics to improve care and outcomes in cancer
Our cancer research focuses on using economic analysis to improve the delivery and outcomes of cancer care. It draws on the Centre’s key methodological strengths including the use of discrete choice experiments to understand the factors that influence patients and providers to participate in care, developing different approaches to the measurement and valuation of quality of life in cancer patients, understanding provider incentives in care, and the use of existing administrative data sets to explore utilization and costs of cancer care. In addition, the principles of economic evaluation underpin a major component of the work in cancer at CHERE: the Cancer Australia Cancer Research Economic Support Team (CREST). CREST provides high quality expert advice and support to the 14 Cancer Australia Multi-site Collaborative Cancer Clinical Trials Groups (CTGs) on the use of health economics approaches, particularly economic evaluation, to evaluate the costs and outcomes of interventions being tested in cancer clinical trials. While a core focus of CREST is on the provision of advice, the ultimate aim of the work is to build capacity within the cancer research community for the conduct of health economic research alongside clinical trials.
Ageing and Palliative Care
Applications of economic analysis to the delivery of aged and palliative care
Ageing and Palliative Care research at CHERE aims to contribute evidence-based economic research and inform policy development in the increasingly important topic of ageing in Australia. We utilize a range of economic analytical tools to evaluate the healthcare and social needs of the aged and those who could benefit from palliative care (including end of life care). Using administrative and operational data sets and data linkages, our analyses inform changes to the financial, organisational and workforce arrangements that aim to improve the delivery of aged and palliative care services. We have a strong policy focus and a proven track record of engagement with governments, consumer groups, providers and financers of these services as well as disseminating our results in academic journals and the broader media.